LOCUS       NM_001302688            1316 bp    mRNA    linear   PRI 24-OCT-2017
DEFINITION  Homo sapiens apolipoprotein E (APOE), transcript variant 1, mRNA.
ACCESSION   NM_001302688 XM_005258867
VERSION     NM_001302688.1
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (bases 1 to 1316)
  AUTHORS   Zhang M, Li Y, Wei X, Tian F, Ouyang F, Zhao S and Liu L.
  TITLE     Indispensable role of lipoprotein bound-ApoE in adipogenesis and
            endocytosis induced by postprandial TRL
  JOURNAL   Biochem. Biophys. Res. Commun. 493 (1), 298-305 (2017)
   PUBMED   28893538
  REMARK    GeneRIF: Taken together, lipoprotein-bound ApoE was required in
            both postprandial TRL-induced adipogenesis and TRL endocytosis by
            the differentiating adipocytes, the latter could be partially
            through low density lipoprotein receptor family dependent-pathway.
REFERENCE   2  (bases 1 to 1316)
  AUTHORS   Amor-Salamanca A, Castillo S, Gonzalez-Vioque E, Dominguez F,
            Quintana L, Lluis-Ganella C, Escudier JM, Ortega J, Lara-Pezzi E,
            Alonso-Pulpon L and Garcia-Pavia P.
  TITLE     Genetically Confirmed Familial Hypercholesterolemia in Patients
            With Acute Coronary Syndrome
  JOURNAL   J. Am. Coll. Cardiol. 70 (14), 1732-1740 (2017)
   PUBMED   28958330
  REMARK    GeneRIF: ApoE associated with Familial Hypercholesterolemia and
            Polygenic Hypercholesterolemia in patients with Acute Coronary
            Syndrome , age </=65 years, and LDL-C levels >/=160 mg/dl.
REFERENCE   3  (bases 1 to 1316)
  AUTHORS   Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy
            R, Beckers L, O'Loughlin E, Xu Y, Fanek Z, Greco DJ, Smith ST,
            Tweet G, Humulock Z, Zrzavy T, Conde-Sanroman P, Gacias M, Weng Z,
            Chen H, Tjon E, Mazaheri F, Hartmann K, Madi A, Ulrich JD, Glatzel
            M, Worthmann A, Heeren J, Budnik B, Lemere C, Ikezu T, Heppner FL,
            Litvak V, Holtzman DM, Lassmann H, Weiner HL, Ochando J, Haass C
            and Butovsky O.
  TITLE     The TREM2-APOE Pathway Drives the Transcriptional Phenotype of
            Dysfunctional Microglia in Neurodegenerative Diseases
  JOURNAL   Immunity 47 (3), 566-581 (2017)
   PUBMED   28930663
  REMARK    GeneRIF: Our work identifies the TREM2-APOE pathway as a major
            regulator of microglial functional phenotype in neurodegenerative
            diseases and serves as a novel target that could aid in the
            restoration of homeostatic microglia.
REFERENCE   4  (bases 1 to 1316)
  AUTHORS   Kim H, Yoo J, Shin J, Chang Y, Jung J, Jo DG, Kim J, Jang W,
            Lengner CJ, Kim BS and Kim J.
  TITLE     Modelling APOE varepsilon3/4 allele-associated sporadic Alzheimer's
            disease in an induced neuron
  JOURNAL   Brain 140 (8), 2193-2209 (2017)
   PUBMED   28899010
  REMARK    GeneRIF: data provide a direct connection between APOE
            varepsilon3/4 and another Alzheimer's disease susceptibility gene
            and demonstrate in proof of principle the utility of induced
            neuron-based modelling of Alzheimer's disease for therapeutic
            discovery
REFERENCE   5  (bases 1 to 1316)
  AUTHORS   Greyshock,N., Guyton,J.R., Sebastian,S. and Okorodudu,D.
  TITLE     APOE p.Leu167del-Related Lipid Disorders
  JOURNAL   (in) Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mefford
            HC, Stephens K, Amemiya A and Ledbetter N (Eds.);
            GENEREVIEWS(R);
            (1993)
   PUBMED   24921113
REFERENCE   6  (bases 1 to 1316)
  AUTHORS   Bird,T.D.
  TITLE     Alzheimer Disease Overview
  JOURNAL   (in) Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mefford
            HC, Stephens K, Amemiya A and Ledbetter N (Eds.);
            GENEREVIEWS(R);
            (1993)
   PUBMED   20301340
REFERENCE   7  (bases 1 to 1316)
  AUTHORS   McLean,J.W., Elshourbagy,N.A., Chang,D.J., Mahley,R.W. and
            Taylor,J.M.
  TITLE     Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing
            of a new variant
  JOURNAL   J. Biol. Chem. 259 (10), 6498-6504 (1984)
   PUBMED   6327682
REFERENCE   8  (bases 1 to 1316)
  AUTHORS   Utermann,G., Pruin,N. and Steinmetz,A.
  TITLE     Polymorphism of apolipoprotein E. III. Effect of a single
            polymorphic gene locus on plasma lipid levels in man
  JOURNAL   Clin. Genet. 15 (1), 63-72 (1979)
   PUBMED   759055
REFERENCE   9  (bases 1 to 1316)
  AUTHORS   Innerarity,T.L., Mahley,R.W., Weisgraber,K.H. and Bersot,T.P.
  TITLE     Apoprotein (E--A-II) complex of human plasma lipoproteins. II.
            Receptor binding activity of a high density lipoprotein subfraction
            modulated by the apo(E--A-II) complex
  JOURNAL   J. Biol. Chem. 253 (17), 6289-6295 (1978)
   PUBMED   210175
REFERENCE   10 (bases 1 to 1316)
  AUTHORS   Weisgraber,K.H. and Mahley,R.W.
  TITLE     Apoprotein (E--A-II) complex of human plasma lipoproteins. I.
            Characterization of this mixed disulfide and its identification in
            a high density lipoprotein subfraction
  JOURNAL   J. Biol. Chem. 253 (17), 6281-6288 (1978)
   PUBMED   210174
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from HY056112.1, BM042032.1,
            BC003557.1 and AL037046.3.
            On Nov 7, 2014 this sequence version replaced gi:530416440.
            
            Summary: The protein encoded by this gene is a major apoprotein of
            the chylomicron. It binds to a specific liver and peripheral cell
            receptor, and is essential for the normal catabolism of
            triglyceride-rich lipoprotein constituents. This gene maps to
            chromosome 19 in a cluster with the related apolipoprotein C1 and
            C2 genes. Mutations in this gene result in familial
            dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III),
            in which increased plasma cholesterol and triglycerides are the
            consequence of impaired clearance of chylomicron and VLDL remnants.
            [provided by RefSeq, Jun 2016].
            
            Transcript Variant: This variant (1) represents the longest
            transcript and encodes the longer isoform (a).
            
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            
            ##Evidence-Data-START##
            Transcript exon combination :: ERR279841.4394.1, ERR279831.1485.1
                                           [ECO:0000332]
            RNAseq introns              :: single sample supports all introns
                                           SAMEA1965299, SAMEA1966682
                                           [ECO:0000348]
            ##Evidence-Data-END##
            COMPLETENESS: complete on the 3' end.
PRIMARY     REFSEQ_SPAN         PRIMARY_IDENTIFIER PRIMARY_SPAN        COMP
            1-68                HY056112.1         1-68
            69-769              BM042032.1         2-702
            770-1295            BC003557.1         617-1142
            1296-1316           AL037046.3         370-390
FEATURES             Location/Qualifiers
     source          1..1316
                     /organism="Homo sapiens"
                     /mol_type="mRNA"
                     /db_xref="taxon:9606"
                     /chromosome="19"
                     /map="19q13.32"
     gene            1..1316
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="apolipoprotein E"
                     /db_xref="GeneID:348"
                     /db_xref="HGNC:HGNC:613"
                     /db_xref="MIM:107741"
     exon            1..175
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /inference="alignment:Splign:2.0.8"
     misc_feature    19..21
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="upstream in-frame stop codon"
     CDS             121..1152
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /note="isoform a precursor is encoded by transcript
                     variant 1; apolipoprotein E3"
                     /codon_start=1
                     /product="apolipoprotein E isoform a precursor"
                     /protein_id="NP_001289617.1"
                     /db_xref="GeneID:348"
                     /db_xref="HGNC:HGNC:613"
                     /db_xref="MIM:107741"
                     /translation="MSSGASRKSWDPGNPWPPDWPITGRKMKVLWAALLVTFLAGCQA
                     KVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQ
                     ELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLV
                     QYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGL
                     SAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEV
                     KEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTS
                     AAPVPSDNH"
     sig_peptide     121..252
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /inference="COORDINATES: ab initio prediction:SignalP:4.0"
     exon            176..241
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /inference="alignment:Splign:2.0.8"
     exon            242..434
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /inference="alignment:Splign:2.0.8"
     STS             364..471
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /standard_name="PMC99927P2"
                     /db_xref="UniSTS:273705"
     exon            435..1297
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /inference="alignment:Splign:2.0.8"
     STS             457..755
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /standard_name="GDB:171177"
                     /db_xref="UniSTS:154776"
     STS             490..755
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /standard_name="GDB:181693"
                     /db_xref="UniSTS:155329"
     STS             519..746
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /standard_name="GDB:169570"
                     /db_xref="UniSTS:154765"
     STS             522..747
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /standard_name="GDB:438097"
                     /db_xref="UniSTS:157265"
     STS             523..793
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /standard_name="GDB:196979"
                     /db_xref="UniSTS:155901"
     STS             532..861
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /standard_name="GDB:177380"
                     /db_xref="UniSTS:154875"
     STS             532..749
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /standard_name="PMC117303P1"
                     /db_xref="UniSTS:270328"
     STS             724..867
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /standard_name="STS-N29699"
                     /db_xref="UniSTS:34644"
     STS             851..1051
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /standard_name="PMC310963P4"
                     /db_xref="UniSTS:272827"
     STS             938..1069
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /standard_name="RH11470"
                     /db_xref="UniSTS:72925"
     STS             1034..1164
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
                     /standard_name="STS-K00396"
                     /db_xref="UniSTS:64138"
     regulatory      1270..1275
                     /regulatory_class="polyA_signal_sequence"
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
     polyA_site      1295
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
     polyA_site      1297
                     /gene="APOE"
                     /gene_synonym="AD2; APO-E; ApoE4; LDLCQ5; LPG"
ORIGIN      
        1 gggacagggg gagccctata attggacaag tctgggatcc ttgagtccta ctcagcccca
       61 gcggaggtga aggacgtcct tccccaggag ccggtgagaa gcgcagtcgg gggcacgggg
      121 atgagctcag gggcctctag aaagagctgg gaccctggga acccctggcc tccagactgg
      181 ccaatcacag gcaggaagat gaaggttctg tgggctgcgt tgctggtcac attcctggca
      241 ggatgccagg ccaaggtgga gcaagcggtg gagacagagc cggagcccga gctgcgccag
      301 cagaccgagt ggcagagcgg ccagcgctgg gaactggcac tgggtcgctt ttgggattac
      361 ctgcgctggg tgcagacact gtctgagcag gtgcaggagg agctgctcag ctcccaggtc
      421 acccaggaac tgagggcgct gatggacgag accatgaagg agttgaaggc ctacaaatcg
      481 gaactggagg aacaactgac cccggtggcg gaggagacgc gggcacggct gtccaaggag
      541 ctgcaggcgg cgcaggcccg gctgggcgcg gacatggagg acgtgtgcgg ccgcctggtg
      601 cagtaccgcg gcgaggtgca ggccatgctc ggccagagca ccgaggagct gcgggtgcgc
      661 ctcgcctccc acctgcgcaa gctgcgtaag cggctcctcc gcgatgccga tgacctgcag
      721 aagcgcctgg cagtgtacca ggccggggcc cgcgagggcg ccgagcgcgg cctcagcgcc
      781 atccgcgagc gcctggggcc cctggtggaa cagggccgcg tgcgggccgc cactgtgggc
      841 tccctggccg gccagccgct acaggagcgg gcccaggcct ggggcgagcg gctgcgcgcg
      901 cggatggagg agatgggcag ccggacccgc gaccgcctgg acgaggtgaa ggagcaggtg
      961 gcggaggtgc gcgccaagct ggaggagcag gcccagcaga tacgcctgca ggccgaggcc
     1021 ttccaggccc gcctcaagag ctggttcgag cccctggtgg aagacatgca gcgccagtgg
     1081 gccgggctgg tggagaaggt gcaggctgcc gtgggcacca gcgccgcccc tgtgcccagc
     1141 gacaatcact gaacgccgaa gcctgcagcc atgcgacccc acgccacccc gtgcctcctg
     1201 cctccgcgca gcctgcagcg ggagaccctg tccccgcccc agccgtcctc ctggggtgga
     1261 ccctagttta ataaagattc accaagtttc acgcatcaaa aaaaaaaaaa aaaaaa
//

